The introduction of biological medicines has revolutionized the management of chronic diseases. Due to the high cost of biological medicine coupled with the fact that patents of many of these medicines are on the verge of expiration. manufacturers are exploring the production of biosimilars. The introduction of biosimilars has the capacity to increase competition among manufacturers. https://www.chiggate.com/biomat-sessions-sale/